Welcome to our new website!
Search
Cancel
Platform
Therapeutics
ioCells™
ioCells™
Discover ioCells
ioCells
ioWild Type Cells
ioDisease Model Cells
Custom cell development
ioWild Type Cells
Nerve cells
ioGlutamatergic Neurons
ioGABAergic Neurons
Immune cells
ioMicroglia
Muscle cells
ioSkeletal Myocytes
ioDisease Model Cells
Huntington's disease
ioGlutamatergic Neurons HTT 50CAG/WT
FTD and ALS
ioGlutamatergic Neurons TDP-43 M337V
ioGlutamatergic Neurons MAPT P301S/WT
ioGlutamatergic Neurons MAPT P301S/P301S
ioGlutamatergic Neurons MAPT N279K/WT
News and Events
News and Events
News
Events
Resources
Resources
Resources
View all
General resources
Application notes
bits of bio
Infographics
Posters
Publications
Talks
Videos
Video tutorials
Webinars
Product information
Brochures
User manuals
Blog
View all articles
Browse topics
CEO views
Culture
Expert-opinion
Leadership
Science
Technology
Sustainability
About
About
Our company
About us
Leadership and Boards
Sustainability
Work with us
Partners
Careers
Careers
Working at bit.bio
Open roles
Employee Spotlights
Contact
Search
Rewriting the story
of human health —
one cell at a time
Empowering biomedical innovation and a new generation of cures through precision reprogrammed human cells
Cell identity coding platform
Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency.
Explore our platform
Therapeutics
Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.
Learn more
ioCells™
Precision reprogrammed human iPSC-derived cells for research and drug discovery.
Discover ioCells
Latest news
Press Release
bit.bio partners with Automata on key aspect of human cell production
26.01.2023
Published by Automata
Read now
CEO views
Key opinions - biotech in 2023: reasons for optimism
16.01.2023
Published by Labiotech.eu
Read now
Article
"Science Meets Design" episode on synthetic biology
23.12.2022
Published by Science Meets Design
Read now
New product
Three new products for neurological and neurodegenerative disease
23.11.2022
Published by bit.bio
Read now